SEC Form 4 · accession 0001437749-26-021238
OMEROS CORP · OMER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leroy E. Hood M.D. Ph.D.
Director
Period of report
Jun 18, 2026
Accepted (ET)
Jun 22, 2026 · 7:34 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001285819
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $10.28 | Jun 18, 2026 | A | 15,000 | A | — | Jun 17, 2036 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.
- F2This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.